Probiotics Prevent Cholera in Animal Models

Two different types of bacteria—one genetically engineered and one from cheese—defend animal intestines from Vibrio cholerae infection.

Written byRuth Williams
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, KTSIMAGEFollowing any vaccination, there is normally a delay of a week or two before protection kicks in, during which time the immune system is gearing up its adaptive response. But a potential new cholera vaccine—created by genetically engineering a nontoxic version of the Vibrio cholerae bacteria—has been shown to exert a probiotic effect that protect rabbits from lethal disease just one day after inoculation.

This probiotic form of protection against cholera also works in mice by giving them Lactococcus lactis bacteria, which is normally found in cheese. Both studies were reported in Science Translational Medicine today (June 13).

“Many times we’ve thought that we’ve conquered cholera,” says Robert Hall of the National Institute of Allergy and Infectious Diseases who was not involved in either research project. But despite the existing vaccines and public health interventions, he says, “still cholera is this huge problem . . . so, it’s really wonderful that scientists are still working on this and they see the risks and are developing contingency plans. That’s a really positive thing.”

The bacterium V. cholerae infects between 3 million and 5 million people worldwide each year and kills ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies